— Know what they know.
Not Investment Advice

HELP

Cybin Inc. Common Stock
1W: +0.0% 1M: -35.5% 3M: -33.8% YTD: -42.6%
$4.75
+0.24 (+5.32%)
After Hours: $4.97 (+0.22, +4.74%)
NASDAQ · Healthcare · Biotechnology · $237.0M · Alpha Radar Strong Sell · Power 28
Smart Money Score
Watch 25
Insider
Congress
ETF Holdings
Key Statistics
Market Cap$237.0M
52W Range4.52-9.83
Volume697,856
Avg Volume835,691
Beta0.88
Dividend
Analyst Ratings
3 Buy 0 Hold 0 Sell
Consensus Buy
Company Info
CEOMichael F. Cola
Employees50
SectorHealthcare
IndustryBiotechnology
IPO Date2019-09-13
Websitecybin.com
100 King Street West
Toronto, ON M5X 1C9
CA
908 764 8385
About Cybin Inc. Common Stock

Clinical-stage biopharmaceutical company developing psychedelic-based therapeutics including CYB003 (deuterated psilocybin analog) for major depressive disorder and CYB004 (deuterated DMT) for generalized anxiety disorder

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms